Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight.  “At this time, there is no other medication like ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how next-gen “small molecule” drugs ...

New research explains the role of genes and other health factors.

GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

Of all the millions of people who have tried weight-loss drugs such as Wegovy and Zepbound, nearly one in four people don’t respond to treatment. They lose little weight, or none at all, and see few ...

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.

The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.